IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Journal of Experimental Therapeutics and Oncology- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on August 7, 2023

Impact Score

0.20

h-Index

 39

Rank

 25669

SJR

 0.107

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Journal of Experimental Therapeutics and Oncology
Abbreviation J. Exp. Ther. Oncol.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q4); Drug Discovery (Q4); Pharmacology (Q4)
h-index 39
Overall Rank/Ranking 25669
SCImago Journal Rank (SJR) 0.107
Impact Score 0.20
Publisher Old City Publishing
Country United States
ISSN 13594117, 1533869X
Best Quartile Q4
Coverage History 1996, 2002-2020




About Journal of Experimental Therapeutics and Oncology


Journal of Experimental Therapeutics and Oncology is a journal covering the technologies/fields/categories related to Cancer Research (Q4); Drug Discovery (Q4); Pharmacology (Q4). It is published by Old City Publishing. The overall rank of Journal of Experimental Therapeutics and Oncology is 25669. According to SCImago Journal Rank (SJR), this journal is ranked 0.107. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 39. The best quartile for this journal is Q4.

The ISSN of Journal of Experimental Therapeutics and Oncology journal is 13594117, 1533869X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Experimental Therapeutics and Oncology is cited by a total of 2 articles during the last 3 years (Preceding 2022).


Journal of Experimental Therapeutics and Oncology Impact Score 2022-2023


The impact score (IS) 2022 of Journal of Experimental Therapeutics and Oncology is 0.20, which is computed in 2023 as per its definition. Journal of Experimental Therapeutics and Oncology IS is increased by a factor of 0 and approximate percentage change is 0% when compared to preceding year 2021, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Journal of Experimental Therapeutics and Oncology Impact Score 2023 Prediction


IS 2022 of Journal of Experimental Therapeutics and Oncology is 0.20. If the same upward trend persists, impact score may rise in 2023 as well.


Impact Score Trend


Year wise Impact Score (IS) of Journal of Experimental Therapeutics and Oncology. Based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.20
2021 0.20
2020 0.46
2019 0.57
2018 0.60
2017 0.44
2016 0.68
2015 0.83
2014 1.68

Journal of Experimental Therapeutics and Oncology h-index


  Table Setting

Journal of Experimental Therapeutics and Oncology has an h-index of 39. It means 39 articles of this journal have more than 39 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Journal of Experimental Therapeutics and Oncology ISSN


The ISSN of Journal of Experimental Therapeutics and Oncology is 13594117, 1533869X. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Journal of Experimental Therapeutics and Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Journal of Experimental Therapeutics and Oncology is 25669. According to SCImago Journal Rank (SJR), this journal is ranked 0.107. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Journal of Experimental Therapeutics and Oncology by Year


Year SJR
2023/2024 Coming Soon
2022 0.107
2021 0.230
2020 0.163
2019 0.231
2018 0.239
2017 0.201
2016 0.273
2015 0.522
2014 0.489

Ranking of Journal of Experimental Therapeutics and Oncology by Year


Year Ranking
2023/2024 Coming Soon
2022 25669
2021 17229
2020 21953
2019 16975
2018 15931
2017 17403
2016 14416
2015 8885
2014 9120

Journal of Experimental Therapeutics and Oncology Publisher


Table Setting

Journal of Experimental Therapeutics and Oncology is published by Old City Publishing. It's publishing house is located in United States. Coverage history of this journal is as following: 1996, 2002-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Journal of Experimental Therapeutics and Oncology is J. Exp. Ther. Oncol.. This abbreviation ('J. Exp. Ther. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Journal of Experimental Therapeutics and Oncology


If your research field is/are related to Cancer Research (Q4); Drug Discovery (Q4); Pharmacology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact index of the Journal of Experimental Therapeutics and Oncology?

The latest impact index of the Journal of Experimental Therapeutics and Oncology is 0.20. It's evaluated in the year 2022. The highest and the lowest impact index or impact score of this journal are 1.68 (2014) and 0.20 (2022), respectively, in the last 9 years. Moreover, its average IS is 0.63 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Journal of Experimental Therapeutics and Oncology?

The Journal of Experimental Therapeutics and Oncology has an SJR (SCImago Journal Rank) of 0.107, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.522 in 2015 and the lowest being 0.107 in 2022. Furthermore, the average SJR of the Journal of Experimental Therapeutics and Oncology over the previous 9-year period stands at 0.63.


What's the latest h-index of the Journal of Experimental Therapeutics and Oncology?

The latest h-index of the Journal of Experimental Therapeutics and Oncology is 39.


Who's the publisher of the Journal of Experimental Therapeutics and Oncology?

The Journal of Experimental Therapeutics and Oncology is published by the Old City Publishing, with its country of publication being the United States.


What's the current ranking of the Journal of Experimental Therapeutics and Oncology?

The Journal of Experimental Therapeutics and Oncology is currently ranked 25669 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 8885 in 2015 and its lowest position of 25669 in 2022.


What's the abbreviation or short name for the Journal of Experimental Therapeutics and Oncology?

The standard ISO4 abbreviation for the Journal of Experimental Therapeutics and Oncology is J. Exp. Ther. Oncol..


Is the "Journal of Experimental Therapeutics and Oncology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Journal of Experimental Therapeutics and Oncology is classified as a journal that the Old City Publishing publishes.


What's the scope or major areas of the Journal of Experimental Therapeutics and Oncology?

The Journal of Experimental Therapeutics and Oncology encompasses the following areas:

  • Cancer Research
  • Drug Discovery
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Journal of Experimental Therapeutics and Oncology?

The Journal of Experimental Therapeutics and Oncology is assigned the following International Standard Serial Numbers (ISSN): 13594117, 1533869X.


What's the best quartile of the Journal of Experimental Therapeutics and Oncology?

The best quartile for the Journal of Experimental Therapeutics and Oncology is Q4 (2022).


What's the coverage history of the Journal of Experimental Therapeutics and Oncology?

The Journal of Experimental Therapeutics and Oncology coverage history can be summarized as follows: 1996, 2002-2020.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Proceedings of the International Symposium on Power Semiconductor Devices and ICs conference and proceedings 7015 49 2.14
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
Criminal Justice Review journal 8738 SAGE Publications Inc. 41 1.30
Journal, Indian Academy of Clinical Medicine journal 24608 Indian Academy of Clinical Medicine 16 0.06
Tekstilec trade journal 19217 Faculty of Natural Sciences and Engineering, Tekstilec 14 0.73
Asian Textile Journal trade journal 27455 G P S Kwatra 10 0.01
Rudarsko Geolosko Naftni Zbornik journal 14294 University of Zagreb, Faculty of Mining, Geology and Petroleum Engineering 17 1.48
East African journal of public health journal 19634 East African Public Health Association 23 0.00
Innovations in Pharmaceutical Technology trade journal 26994 Samedan Ltd 9 0.00
Asian Journal of Animal and Veterinary Advances (discontinued) journal 15083 Academic Journals Inc. 28 3.00

Check complete list




Year wise Impact Score (IS) of Journal of Experimental Therapeutics and Oncology

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.20
2021 0.20
2020 0.46
2019 0.57
2018 0.60
2017 0.44
2016 0.68
2015 0.83
2014 1.68



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All